Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Intensity Therapeutics Inc. (INTS) had Debt to Capital Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.05M |
|
-- |
|
-- |
|
$3.14M |
|
$-3.14M |
|
$0.09M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
$-3.05M |
|
$-3.14M |
|
$-3.13M |
|
1.36M |
|
1.36M |
|
$1.69 |
|
$1.69 |
|
| Balance Sheet Financials | |
$12.71M |
|
-- |
|
$1.39M |
|
$14.10M |
|
$2.15M |
|
$0.08M |
|
$0.08M |
|
$2.23M |
|
$11.88M |
|
$11.88M |
|
$11.88M |
|
2.52M |
|
| Cash Flow Statement Financials | |
$-9.23M |
|
-- |
|
$18.56M |
|
$2.59M |
|
$11.92M |
|
$9.33M |
|
$2.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.92 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.01 |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.69% |
|
-25.69% |
|
-21.64% |
|
-25.52% |
|
$4.71 |
|
$-6.81 |
|
$-6.81 |
|